NCT07251738 · NOT YET RECRUITING
Understanding the Lived Experience and Bereavement of Caregivers of People With Alzheimer's Disease
This study is not testing a drug or treatment. It is interviewing and surveying family caregivers of people with Alzheimer's disease to understand how the caregiving experience affects their own well-being, daily life, and sense of burden — including the grief period after a loved one dies. The phase is unspecified, and this is observational research, meaning no intervention is being given to participants.
You may qualify if
- Inclusion criteria for Group 1: relatives of people diagnosed with AD by a neurologist or geriatrician, who have suffered the loss of a relative with AD; who have lived with and/or cared for the person with AD until the end of their life; who agree to participate voluntarily in the project and who have signed the informed consent form.
- Inclusion criteria for Group 2: relatives of people diagnosed with AD by a neurologist or geriatrician; who live with and/or care for the person with AD; who attend the Day Centre and who agree to participate voluntarily in the project and have signed the informed consent form.
- Inclusion criteria for Group 3: relatives of people diagnosed with AD by a neurologist or geriatrician; who have their relative institutionalised in a nursing home and who agree to participate voluntarily in the project and have signed the informed consent form.
You're excluded if
- Those who have not lived with or cared for relatives with AD and who do not agree to participate in the study will be excluded from the project.
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2025-11-26